167
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Association Between Early Administration of Norepinephrine in Septic Shock and Survival

ORCID Icon &
Pages 143-150 | Published online: 31 Mar 2021

References

  • Rahnema A, Jones J. Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial. J Emerg Med. 2019;56(6):729–730. doi:10.1016/j.jemermed.2019.05.004
  • Russell J, Lee T, Singer J, De Backer D, Annane D. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials. J Crit Care. 2018;47:333–337. doi:10.1016/j.jcrc.2018.05.003
  • Maheshwari K, Nathanson B, Munson S, et al. The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients. Intensive Care Med. 2018;44(6):857–867. doi:10.1007/s00134-018-5218-5
  • Rowan K, Angus D, Bailey M, Barnato A. Early, goal-directed therapy for septic shock—a patient-level meta-analysis. N Engl J Med. 2017;376(23):2223–2234.
  • Watkins R, Haller N, Wayde M, Armitage K. A multicenter survey of house staff knowledge about sepsis and the “surviving sepsis campaign guidelines for management of severe sepsis and septic shock”. J Intensive Care Med. 2017;35(2):187–190. doi:10.1177/0885066617737304
  • Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med. 2019;199(9):1097–1105. doi:10.1164/rccm.201806-1034OC
  • Vail E, Gershengorn H, Hua M, Walkey A, Rubenfeld G, Wunsch H. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA. 2017;317(14):1433. doi:10.1001/jama.2017.2841
  • Ospina-Tascón G, Hernandez G, Alvarez I, et al. Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis. Critical Care. 2020;24(1):1–11. doi:10.1186/s13054-020-2756-3
  • Levy M, Dellinger R, Townsend S, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis*. Crit Care Med. 2010;38(2):367–374. doi:10.1097/CCM.0b013e3181cb0cdc
  • Levy M, Rhodes A, Phillips G, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014;40(11):1623–1633. doi:10.1007/s00134-014-3496-0
  • Zanotti-Cavazzoni S. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Yearbook Crit Care Med. 2008;2008:168–170. doi:10.1016/S0734-3299(08)70552-5
  • Comstock G. Time to treatment and mortality during mandated emergency care for sepsis. J Emerg Med. 2017;53(4):602–603. doi:10.1016/j.jemermed.2017.08.088
  • Hamzaoui O, Jozwiak M, Geffriaud T, et al. Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br J Anaesth. 2018;120(3):517–524. doi:10.1016/j.bja.2017.11.065
  • Spoelstra - de Man A, Girbes A. Comment on “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008” by Dellinger et al. Intensive Care Med. 2008;34(6):1160–1162. doi:10.1007/s00134-008-1089-5
  • Bai X, Yu W, Ji W, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Critical Care. 2014;18(5):532. doi:10.1186/s13054-014-0532-y